Influence of Rosiglitazone on the Expression of PPARγ, NF-κB, and TNF-α in Rat Model of Ulcerative Colitis : Table 2

Table 2: DAI and CMDI of three groups on different time (mean SD).


Time	Control group		Model group		Rosiglitazone-treatedgroup
Time	DAI	CMDI	DAI	CMDI	DAI	CMDI

7th day			*	*
14th day			*	*
21st day			*	*
35th day			*	*

Note: * versus control group, ^Δ versus model group.